Genome & Company is a Korean biotech company applying high throughput screening, sophisticated analytics, and multi-omics to identify and develop naturally occurring microbiome to improve health. Currently, the company develops microbiome in oncology, metabolism, and skin area. The company is also developing monoclonal antibody therapeutics directed at the novel I/O targets. These programs are in the early preclinical stage of development.
Session ID: 561016